Kathy Seidl, PhD

15+ years career in drug discovery and development in biotech and large pharma. Deep immunology expertise across modalities for autoimmune and oncology indications. Genetics PhD from Stanford with postdoctoral training at Harvard Medical. Previous roles include leadership positions at bluebird, Novartis, Pfizer, Wyeth, and Daiamed.